Patent details

Basic Information

Publication number:

91291

Type:

SPC

SPC Type:

Medical

Basic Patent Number:

EP979282696

Legal Status:

Expired

Application number:

91291

First applicant's nationality:

Procedural language:

French

Paediatric Extension

SPC Extension Filing Date:

30/05/2018

SPC Extension Agent Name:

OFFICE FREYLINGER S.A.

SPC Extension Status:

Granted

SPC Extension Grant Date:

27/12/2018

SPC Extension Rejection Date:

Marketing Authorization

Marketing Authorization Number:

EU/1/06/356/001-006

Marketing Authorization Type:

Marketing Authorization Date:

30/08/2006

Marketing Authorization Status:

Accepted

Marketing Authorization Country:

Luxembourg (LU)

Dates

Filing date:

29/11/2006

First Marketing Authorization date:

30/08/2006

Grant date:

29/01/2007

Activation date:

24/06/2017

Publication date:

29/01/2007

Lapsed date:

Expiration date:

Renunciation date:

Revocation date:

Annulment date:

Basic SPC Expiration:

30/08/2021

SPC Extension Expiration:

28/02/2022

Rejection date:

Withdrawal date:

Owner

From:

29/11/2006

 

 

Name:

NOVARTIS AG

Address:

LICHTSTRASSE 35, 4056, BASEL, Switzerland (CH)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

29/11/2006

Address:

Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

ACKLIN Pierre

Address:

Switzerland (CH)

2

Name:

LATTMANN René

Address:

Switzerland (CH)

Licencee

Name:

NOVARTIS PHARMA NV

From:

16/02/2022

Address:

Medialaan 40, 1800, Vilvoorde, Belgium (BE)

To:

16/02/2022

Publication

Bulletin

1

Bulletin Heading:

SPC3

Bulletin edition number:

2017/03

Publication date:

21/07/2017

Description:

Section E : Supplementary Protection certificates entered into force – IA publication

2

Bulletin Heading:

SPC4

Bulletin edition number:

2019/01

Publication date:

09/01/2019

Description:

Section F : Correction of granted supplementary protection certificates – I9 publication

3

Bulletin Heading:

SPCX2

Bulletin edition number:

2019/01

Publication date:

09/01/2019

Description:

Section H : Granted extensions for pediatric use of supplementary protection certificates – I2E publication

4

Bulletin Heading:

SPCX1

Bulletin edition number:

2018/08

Publication date:

06/07/2018

Description:

Section G : Applications for extensions for pediatric use – I1E publication

5

Bulletin Heading:

MED

Bulletin edition number:

2022/04

Publication date:

04/03/2022

Description:

Section K : Modifications and recordals into the register

Deed

Licence

Change Kind/ Decision Type:

New licence registration

Deed Number:

RC20220000048A

Date Registered:

16/02/2022

Licence Effective Date:

06/07/2021

Licence Expiration Date:

28/02/2022

Scope of Licence:

Not Exclusive

Deed Filer:

ETUDE DECKER ET BRAUN

Journal Edition Number:

Text:

Country Code:

Luxembourg (LU)

Updated Licence Number:

Terminated Licence Number:

Added Licencee(s)

Name:

NOVARTIS PHARMA NV

Address:

Medialaan 40, 1800, Vilvoorde, Belgium (BE)

Removed Pledgee

Name:

Address:

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

10/06/2021

Last Annual Fee Paid Number:

25

Last Annual Fee Paid Amount:

450 Euro

Payer:

CPA GLOBAL THE IP PLATFORM

Filing date	Document type	Number of pages
17/02/2022	Request For Change	5
21/02/2022	Outgoing Correspondence	1
30/05/2018	General Document	5
30/05/2018	General Document	36
27/12/2018	Certificate	1
27/12/2018	Publication	1
27/12/2018	Outgoing Correspondence	1
25/04/2018	Incoming Correspondence (Post)	2
30/05/2018	General Document	1
30/05/2018	Incoming Correspondence (Post)	3
30/05/2018	Application Form	4
19/07/2016	Incoming Correspondence (Post)	2
01/06/2018	FNET_DC_FRONTPAGE	1
30/05/2018	General Document	4
30/05/2018	General Document	1
01/06/2018	Publication	1
27/12/2018	Outgoing Correspondence	1
01/06/2018	Outgoing Correspondence	1
27/12/2018	Publication	1
30/05/2018	General Document	1